NO20003694L - VLA-4 antagonists - Google Patents
VLA-4 antagonistsInfo
- Publication number
- NO20003694L NO20003694L NO20003694A NO20003694A NO20003694L NO 20003694 L NO20003694 L NO 20003694L NO 20003694 A NO20003694 A NO 20003694A NO 20003694 A NO20003694 A NO 20003694A NO 20003694 L NO20003694 L NO 20003694L
- Authority
- NO
- Norway
- Prior art keywords
- vla
- antagonists
- inflammatory
- useful
- therapeutic
- Prior art date
Links
- 108010008212 Integrin alpha4beta1 Proteins 0.000 title abstract 2
- 239000005557 antagonist Substances 0.000 title abstract 2
- 230000002757 inflammatory effect Effects 0.000 abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 230000021164 cell adhesion Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000001356 surgical procedure Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Forbindelser med formel I og deres farmasøytisk akseptable salter er VLA-4-antagonister. De er nyttige ved hem- ming av celleadhesjon og ved den terapeutisk og profylaktiske behandlingen av Ln- fiammatoriske og autoimmune sykdommer, spesielt inflammatoriske luftveissykdom- mer. De er spesielt nyttige for å redusere post-kirurgisk inflammasjon, spesielt den som er et resultat av transplantasjonskirurgi.Compounds of formula I and their pharmaceutically acceptable salts are VLA-4 antagonists. They are useful in inhibiting cell adhesion and in the therapeutic and prophylactic treatment of inflammatory and autoimmune diseases, especially inflammatory respiratory diseases. They are particularly useful for reducing post-surgical inflammation, especially that resulting from transplant surgery.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1233698A | 1998-01-23 | 1998-01-23 | |
| US11072398P | 1998-12-03 | 1998-12-03 | |
| PCT/EP1999/000384 WO1999037605A1 (en) | 1998-01-23 | 1999-01-21 | Vla-4 antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20003694D0 NO20003694D0 (en) | 2000-07-19 |
| NO20003694L true NO20003694L (en) | 2000-09-20 |
Family
ID=26683440
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20003694A NO20003694L (en) | 1998-01-23 | 2000-07-19 | VLA-4 antagonists |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1049665A1 (en) |
| JP (1) | JP4564654B2 (en) |
| KR (1) | KR20010034317A (en) |
| CN (1) | CN1294576A (en) |
| AU (1) | AU746174B2 (en) |
| BR (1) | BR9907733A (en) |
| CA (1) | CA2318639A1 (en) |
| EE (1) | EE200000428A (en) |
| HU (1) | HUP0100336A3 (en) |
| ID (1) | ID26665A (en) |
| IL (1) | IL137329A0 (en) |
| NO (1) | NO20003694L (en) |
| WO (1) | WO1999037605A1 (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2623900A (en) * | 1999-01-22 | 2000-08-07 | American Home Products Corporation | Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| IL143929A0 (en) | 1999-01-22 | 2002-04-21 | Elan Pharm Inc | Acyl derivatives which treat vla-4 related disorders |
| US6436904B1 (en) | 1999-01-25 | 2002-08-20 | Elan Pharmaceuticals, Inc. | Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| JP2002538135A (en) | 1999-03-01 | 2002-11-12 | エラン ファーマシューティカルズ，インコーポレイテッド | α-aminoacetic acid derivatives useful as α4β7 receptor antagonists |
| WO2001042192A2 (en) * | 1999-12-07 | 2001-06-14 | Novartis Ag | Vla-4 integrin antagonists |
| PL357109A1 (en) | 1999-12-28 | 2004-07-12 | Pfizer Products Inc. | Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| DE10019755A1 (en) * | 2000-04-20 | 2001-11-08 | Bayer Ag | New cyclic carboxylic acids are integrin antagonists, useful for treating inflammatory diseases, autoimmune and immune disorders, e.g. atherosclerosis, asthma and diabetes |
| GB2367816A (en) | 2000-10-09 | 2002-04-17 | Bayer Ag | Urea- and thiourea-containing derivatives of beta-amino acids |
| GB2369357A (en) * | 2000-10-09 | 2002-05-29 | Bayer Ag | Aliphatic, cyclic amino carboxylic acids as integrin antagonists |
| GB2377933A (en) | 2001-07-06 | 2003-01-29 | Bayer Ag | Succinic acid derivatives useful as integrin antagonists |
| TWI281470B (en) | 2002-05-24 | 2007-05-21 | Elan Pharm Inc | Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins |
| TW200307671A (en) | 2002-05-24 | 2003-12-16 | Elan Pharm Inc | Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins |
| TW200610754A (en) * | 2004-06-14 | 2006-04-01 | Daiichi Seiyaku Co | Vla-4 inhibitor |
| GB0523576D0 (en) * | 2005-11-18 | 2005-12-28 | Theradeas Ltd | Drug composition and its use in therapy |
| KR20080100271A (en) | 2006-02-27 | 2008-11-14 | 엘란 파마슈티칼스, 인크. | Pyrimidinyl sulfonamide compounds that inhibit leukocyte adhesion mediated by JLA-4 |
| US20100150915A1 (en) | 2007-02-20 | 2010-06-17 | Stewart Edward J | Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist |
| EA022201B1 (en) | 2008-04-11 | 2015-11-30 | Мерримак Фармасьютикалз, Инк. | Agent capable for binding to tumor cell comprising human serum albumin (hsa) linker and use thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6306840B1 (en) * | 1995-01-23 | 2001-10-23 | Biogen, Inc. | Cell adhesion inhibitors |
| ES2235383T3 (en) * | 1997-12-23 | 2005-07-01 | Aventis Pharma Limited | BETA-ALANINAS SUBSTITUTED. |
-
1999
- 1999-01-21 BR BR9907733-7A patent/BR9907733A/en not_active IP Right Cessation
- 1999-01-21 EP EP99908811A patent/EP1049665A1/en not_active Withdrawn
- 1999-01-21 WO PCT/EP1999/000384 patent/WO1999037605A1/en not_active Ceased
- 1999-01-21 IL IL13732999A patent/IL137329A0/en unknown
- 1999-01-21 AU AU28292/99A patent/AU746174B2/en not_active Ceased
- 1999-01-21 EE EEP200000428A patent/EE200000428A/en unknown
- 1999-01-21 KR KR1020007008039A patent/KR20010034317A/en not_active Withdrawn
- 1999-01-21 CA CA002318639A patent/CA2318639A1/en not_active Abandoned
- 1999-01-21 ID IDW20001404A patent/ID26665A/en unknown
- 1999-01-21 HU HU0100336A patent/HUP0100336A3/en unknown
- 1999-01-21 CN CN99803780A patent/CN1294576A/en active Pending
- 1999-01-21 JP JP2000528529A patent/JP4564654B2/en not_active Expired - Fee Related
-
2000
- 2000-07-19 NO NO20003694A patent/NO20003694L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ID26665A (en) | 2001-01-25 |
| CN1294576A (en) | 2001-05-09 |
| EE200000428A (en) | 2001-12-17 |
| HUP0100336A3 (en) | 2002-11-28 |
| HUP0100336A2 (en) | 2001-07-30 |
| JP4564654B2 (en) | 2010-10-20 |
| NO20003694D0 (en) | 2000-07-19 |
| JP2002501039A (en) | 2002-01-15 |
| AU2829299A (en) | 1999-08-09 |
| KR20010034317A (en) | 2001-04-25 |
| EP1049665A1 (en) | 2000-11-08 |
| IL137329A0 (en) | 2001-07-24 |
| BR9907733A (en) | 2000-10-17 |
| CA2318639A1 (en) | 1999-07-29 |
| WO1999037605A1 (en) | 1999-07-29 |
| AU746174B2 (en) | 2002-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20003694L (en) | VLA-4 antagonists | |
| NO982731L (en) | Antagonists of gonadotropin-releasing hormone | |
| MY127126A (en) | Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation | |
| DE60045508D1 (en) | DALDA ANALOGS AND THEIR USE | |
| JO2282B1 (en) | Oxazol derivatives | |
| NO20062692L (en) | Heterocyclic MEK inhibitors and methods for their use | |
| YU20999A (en) | Heterocycle derivatives which inhibit faktor xa | |
| DE602004011394D1 (en) | Thiazolderivate | |
| NO20073465L (en) | Benzothiazole derivatives | |
| WO2005047244A3 (en) | Inhibition of fgfr3 and treatment of multiple myeloma | |
| NO20031024L (en) | Bicyclic pyrrolyl amides as glucogenic phosphorylase inhibitors | |
| NO20062704L (en) | Azabicyclic heterocycles as cannabinoid receptor modulators | |
| IL158975A0 (en) | 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors | |
| NZ545506A (en) | Therapeutic agents useful for treating pain | |
| NO20021328L (en) | Pyrazolopyrimidia as therapeutic agents | |
| DE60315674D1 (en) | NEW IMIDAZOPYRIDINE AND ITS USE | |
| UA49869C2 (en) | NAPHTHYL-SUBSTITUTED BENZIMIDAZOLE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, METHOD FOR TREATMENT (VARIANTS), METHOD FOR INHIBITING HUMAN FACTOR Xa OR IIa | |
| MXPA05010958A (en) | Indazole derivatives as jnk inhibitors. | |
| WO2001068586A3 (en) | α4β1 AND α4β7 INTEGRIN INHIBITORS | |
| NO20050851L (en) | Caspase Inhibitors and Uses thereof | |
| NO991761L (en) | New piperidine cotocarboxylic acid derivatives, their preparation and use | |
| ATE301654T1 (en) | NAPHTHYRIDINE DERIVATIVES | |
| NO990433L (en) | New compounds and compositions for the treatment of diseases associated with tryptase activity | |
| NO954878L (en) | pyrrole | |
| DE60322417D1 (en) | 4-oxo-1-(3-substituiertesphenyl)-1,4-dihydro-1,8-naphthyridin-3-carbonsäureamide alsphoshodiesterase-4-inhibitoren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |